MARLBOROUGH, Mass., March 3, 2021 / PRNewswire / – Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement with a subsidiary of Baring Private Equity Asia (BPEA) to acquire the global surgical business of Lumenis LTD. , a private company that develops and markets energy-based medical solutions, for an upfront cash payment of $ 1.07 billion, subject to closing adjustments. BPEA will retain ownership of Lumenis’ global aesthetics and ophthalmology businesses. With net sales of approximately $ 200 million in 2021, Lumenis’ surgical business includes top-notch laser systems, fibers and accessories used for urology and otolaryngology procedures. The exclusive MOSES ™ technology is the basis of its urology portfolio,…
News Highlights Business
- Headline: Boston Scientific announces an agreement to acquire Lumenis LTD. Surgical company From Baring Private Equity Asia
- Check all news and articles from the Business news updates.